BioCentury This Week Podcast Artwork Image

BioCentury This Week

BioCentury

BioCentury's streaming commentary on biotech industry trends, plus interviews with leading KOLs. For three decades, BioCentury has given biopharma executives, investors and institutions the power to make business-critical decisions through independent, deep-dive analysis; high-quality data; industry-leading business intelligence; and global conferences.

Ep. 228 - Energizing Gene Therapy. Plus: AI Newco, Ono-DecipheraApril 29, 2024
Episode artwork
Ep. 227 - Defending Accelerated Approval. Plus: Endpoint Innovation & AIM AmissApril 22, 2024
Episode artwork
Ep. 226 - Vertex’s Alpine Buy, Goldman’s Venture & IRA Tea LeavesApril 15, 2024
Episode artwork
Ep. 225 - 2Q Markets Preview & AACR TakeawaysApril 08, 2024
Episode artwork
Ep. 224 - Biotech IPOs, Avalon & FDA at SCOTUSApril 01, 2024
Episode artwork
Ep. 223 - Biosecure, Bruce Booth & Ultrarare DrugsMarch 25, 2024
Episode artwork
Ep. 222 - Crowley’s Vision for BIO, Plus: MASH & CAR TsMarch 18, 2024
Episode artwork
Ep. 221 - China Biocontroversy, Plus: Diversity MattersMarch 11, 2024
Episode artwork
Ep. 220 - Biotech’s Financing Flurry & Distillery SpotlightMarch 04, 2024
Episode artwork
Ep. 219 - East-West Summit PreviewFebruary 27, 2024
Episode artwork
Ep. 218 - Bob Nelsen Insights, TL1A, Rare DiseasesFebruary 26, 2024
Episode artwork
Ep. 217 - Safer CAR Ts & World’s First TIL TherapyFebruary 20, 2024
Episode artwork
Ep. 216 - Anti-China Biotech Policy: Biosecure & BeyondFebruary 15, 2024
Episode artwork
Ep. 215 - ADCs, Psychedelics & IPOsFebruary 12, 2024
Episode artwork
Ep. 214 - BMS’s Patent Cliff, Congress Targets China BiotechFebruary 05, 2024
Episode artwork
Ep. 213 - Biotech IPOs & IL-18 Momentum January 29, 2024
Episode artwork
Ep. 212 - 2024 Buyside View & Arnold Ventures' ImpactJanuary 22, 2024
Episode artwork
Ep. 211 - 2024 Markets Preview, Woodcock's LegacyJanuary 16, 2024
Episode artwork
Ep. 210 - J.P. Morgan Healthcare Conference WrapJanuary 12, 2024
Episode artwork
Ep. 209 - Biotech M&A, Innovation, Public Policy in 2024January 04, 2024
Episode artwork
Ep. 208 - XBI Rally, ASH Highlights & '24 PicksDecember 18, 2023
Episode artwork
Ep. 207 - Sickle Cell, AbbVie Deals, BIO CEO, March-inDecember 11, 2023
Episode artwork
Ep. 206 - Roche, AbbVie Deals; Plus: FDA & CAR TDecember 04, 2023
Episode artwork
Ep. 205 - Radiotherapy Deep Dive; Plus: Congress, BioNTech November 27, 2023
Episode artwork
Ep. 204 - First CRISPR Approval & IRA’s Lost Orphans November 20, 2023
Episode artwork